Real-time enrollment status for this myeloma multiple clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 11:05 AM UTC
| NCT Number | NCT07085728 |
| Recruiting Status | Recruiting |
| Condition | Myeloma Multiple |
| Phase | PHASE2 |
| Target Enrollment | 74 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Eastern Cooperative Oncology Group |
| Last Updated on CT.gov | September 14, 2026 (Sep 14, 2026) |
As of October 16, 2026: Clinical trial NCT07085728 is currently recruiting participants. This phase2 study for myeloma multiple is actively seeking new participants at 1 location across the United States. The study is sponsored by Eastern Cooperative Oncology Group. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07085728 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07085728 was last updated Sep 14, 2026 (September 14, 2026). HelloStudys verifies this status automatically.